FOXO TECHNOLOGIES INC. Interest Expense
FOXO TECHNOLOGIES INC. (FOXO) reported Interest Expense of $42.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-06-28
- FOXO TECHNOLOGIES INC. interest expense for the quarter ending 2024-03-31 was $42.00K, a 81.33% decline year-over-year.
- FOXO TECHNOLOGIES INC. interest expense for the quarter ending 2023-09-30 was $148.00K, a 65.09% decline year-over-year.
- FOXO TECHNOLOGIES INC. interest expense for the quarter ending 2023-06-30 was $492.00K, a 2.38% decline year-over-year.
- FOXO TECHNOLOGIES INC. interest expense for the quarter ending 2023-03-31 was $225.00K, a 30.12% decline year-over-year.
- FOXO TECHNOLOGIES INC. interest expense for fiscal 2022 was $1.44M, a 28.80% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. interest expense for fiscal 2021 was $1.12M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $42.00K 10-Q · filed 2024-06-28 | |||
| 2023-09-30 | $148.00K 10-Q/A · filed 2024-06-04 | $640.00K derived: sum of 2 quarters · filed 2024-06-04 | $865.00K 10-Q/A · filed 2024-06-04 | $1.05M derived: sum of 4 quarters · filed 2024-06-04 |
| 2023-06-30 | $492.00K 10-Q · filed 2023-08-10 | $717.00K 10-Q · filed 2023-08-10 | $907.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.33M derived: sum of 4 quarters · filed 2024-06-04 |
| 2023-03-31 | $225.00K 10-Q · filed 2023-05-11 | $415.00K derived: sum of 2 quarters · filed 2023-05-11 | $839.00K derived: sum of 3 quarters · filed 2024-06-04 | $1.34M derived: sum of 4 quarters · filed 2024-06-04 |
| 2022-12-31 | $190.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | $614.00K derived: sum of 2 quarters · filed 2024-06-04 | $1.12M derived: sum of 3 quarters · filed 2024-06-04 | $1.44M 10-K · filed 2023-03-31 |
| 2022-09-30 | $424.00K 10-Q/A · filed 2024-06-04 | $928.00K derived: sum of 2 quarters · filed 2024-06-04 | $1.25M 10-Q/A · filed 2024-06-04 | $1.54M derived: sum of 4 quarters · filed 2024-06-04 |
| 2022-06-30 | $504.00K 10-Q · filed 2023-08-10 | $826.00K 10-Q · filed 2023-08-10 | $1.12M derived: sum of 3 quarters · filed 2023-08-10 | $1.43M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $322.00K 10-Q · filed 2023-05-11 | $615.00K derived: sum of 2 quarters · filed 2023-05-11 | $928.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $606.00K derived: sum of 2 quarters · filed 2023-03-31 | $1.12M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $313.00K 10-Q · filed 2022-11-21 | $825.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |